CN Patent

CN102260252A — 可用于治疗细菌感染的新噁唑烷酮

Assigned to MICURX PHARMACEUTICAL Inc · Expires 2011-11-30 · 14y expired

What this patent protects

本发明提供了具有下列式I的可作为抗菌药物的新型取代B环噁唑烷酮： 或其药学上可接受的盐、药物前体、或含有该噁唑烷酮的药物组合物，其使用方法以及制备方法。

USPTO Abstract

本发明提供了具有下列式I的可作为抗菌药物的新型取代B环噁唑烷酮： 或其药学上可接受的盐、药物前体、或含有该噁唑烷酮的药物组合物，其使用方法以及制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102260252A
Jurisdiction
CN
Classification
—
Expires
2011-11-30
Drug substance claim
No
Drug product claim
No
Assignee
MICURX PHARMACEUTICAL Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.